ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,680.29
0.56%
Dow Jones
41,841.63
0.85%
Gold vs US Dollar
3,014.14
0.45%
Brent Oil
70.975
0.45%
Bitcoin
82,973.66
-1.29%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) News

Cue Biopharma (CUE)

Cue Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CUE
DateTimeSourceHeadlineSymbolCompany
12/03/202520:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
12/03/202520:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
12/03/202520:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/01/202521:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/01/202521:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
29/11/202421:30GlobeNewswire Inc.Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CUECue Biopharma Inc
29/11/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
29/11/202421:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
25/11/202413:00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
14/11/202421:05GlobeNewswire Inc.Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CUECue Biopharma Inc
14/11/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CUECue Biopharma Inc
14/11/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
14/11/202413:00GlobeNewswire Inc.Cue Biopharma Announces Strategic Organizational TransitionNASDAQ:CUECue Biopharma Inc
12/11/202413:00GlobeNewswire Inc.Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare ConferenceNASDAQ:CUECue Biopharma Inc
08/11/202418:30GlobeNewswire Inc.Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
08/10/202420:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
07/10/202421:07Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CUECue Biopharma Inc
04/10/202420:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
04/10/202413:00GlobeNewswire Inc.Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNASDAQ:CUECue Biopharma Inc
27/09/202420:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
27/09/202420:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CUECue Biopharma Inc
27/09/202403:26GlobeNewswire Inc.Cue Biopharma Announces Pricing of $12.0 Million Public OfferingNASDAQ:CUECue Biopharma Inc
27/09/202403:10GlobeNewswire Inc.Cue Biopharma Announces Proposed Public OfferingNASDAQ:CUECue Biopharma Inc
26/09/202420:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CUECue Biopharma Inc
26/09/202420:27GlobeNewswire Inc.Cue Biopharma Announces Proposed Public OfferingNASDAQ:CUECue Biopharma Inc
10/09/202420:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CUECue Biopharma Inc
09/09/202412:00GlobeNewswire Inc.Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business OfficerNASDAQ:CUECue Biopharma Inc
05/09/202420:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
05/09/202420:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CUECue Biopharma Inc
03/09/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CUECue Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:CUE

Your Recent History

TG
WTRD
WisdomTree Issuer ICAV
TG
B1X
Rbc Bearings Inc Dl 01
TG
PPX
Kering
TG
P3W8
Invesco Capital Management
BIT
GFA
VanEck Global Fallen Ang...
TG
H41K
HSBC Securities Services...
TSX
FDY
Faraday Copper
TG
NTSG
Wisdomtree Global Effici...
NYSE
PAM
Pampa Energia
TG
V3DL
Vanguard Esg Developed E...
TG
BATF
Legal & General Ucits Etf
NASDAQ
ESSC
East Stone Acquisition
ASX
ENV
Enova Mining
TG
VAGY
Vanguard Funds
ASX
WTM
Waratah Minerals
TG
BS26
Invesco Markets Ii
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads